The global Moyamoya Disease market size was valued at USD 1.89 billion in 2024 and is expected to reach USD 3.27 billion by 2032, at a CAGR of 7.10% during the forecast period
The market growth is largely fueled by the increasing prevalence of cerebrovascular disorders and the growing advancements in diagnostic imaging technologies, which have significantly improved the early detection and management of Moyamoya disease
Furthermore, rising awareness of rare neurological conditions, coupled with ongoing research in surgical revascularization techniques and innovative treatment approaches, is accelerating the adoption of moyamoya disease management solutions, thereby significantly boosting the industry's growth
2 Views